Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cocaine | 21 | 2021 | 1007 | 4.660 |
Why?
|
Methamphetamine | 7 | 2021 | 154 | 2.360 |
Why?
|
Nicotine | 8 | 2019 | 681 | 2.220 |
Why?
|
Central Nervous System Stimulants | 11 | 2021 | 1148 | 2.200 |
Why?
|
Conditioning, Operant | 17 | 2019 | 313 | 1.770 |
Why?
|
Macaca mulatta | 16 | 2024 | 2375 | 1.700 |
Why?
|
Self Administration | 20 | 2021 | 385 | 1.640 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 5 | 2021 | 422 | 1.520 |
Why?
|
Cocaine-Related Disorders | 8 | 2019 | 460 | 1.450 |
Why?
|
Discrimination Learning | 4 | 2021 | 280 | 1.180 |
Why?
|
Benzazepines | 3 | 2018 | 326 | 1.170 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 3 | 2021 | 322 | 1.060 |
Why?
|
Alkaloids | 4 | 2021 | 190 | 1.030 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 2 | 2017 | 66 | 1.030 |
Why?
|
Behavior, Animal | 8 | 2021 | 1881 | 0.950 |
Why?
|
Food | 6 | 2019 | 771 | 0.920 |
Why?
|
Dopamine Uptake Inhibitors | 7 | 2019 | 312 | 0.810 |
Why?
|
Dose-Response Relationship, Drug | 19 | 2021 | 10943 | 0.780 |
Why?
|
Eating | 6 | 2019 | 1536 | 0.730 |
Why?
|
Saccharin | 3 | 2010 | 20 | 0.700 |
Why?
|
Heroin | 1 | 2018 | 117 | 0.630 |
Why?
|
Bupropion | 1 | 2019 | 303 | 0.610 |
Why?
|
Behavior, Addictive | 5 | 2019 | 462 | 0.570 |
Why?
|
Reinforcement Schedule | 6 | 2017 | 129 | 0.570 |
Why?
|
Buspirone | 2 | 2013 | 82 | 0.530 |
Why?
|
Propiophenones | 2 | 2021 | 30 | 0.510 |
Why?
|
Wakefulness | 1 | 2022 | 1245 | 0.510 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2015 | 189 | 0.490 |
Why?
|
Choice Behavior | 2 | 2018 | 803 | 0.460 |
Why?
|
Anti-Anxiety Agents | 2 | 2013 | 390 | 0.450 |
Why?
|
Dopamine | 3 | 2017 | 1591 | 0.440 |
Why?
|
Clonidine | 1 | 2013 | 164 | 0.440 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2013 | 87 | 0.430 |
Why?
|
Maternal Deprivation | 2 | 2008 | 48 | 0.400 |
Why?
|
Nucleus Accumbens | 1 | 2014 | 366 | 0.400 |
Why?
|
Receptor, Serotonin, 5-HT2C | 4 | 2022 | 44 | 0.390 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2021 | 65 | 0.380 |
Why?
|
Opioid-Related Disorders | 2 | 2024 | 2065 | 0.380 |
Why?
|
Animals | 39 | 2024 | 168757 | 0.370 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3760 | 0.370 |
Why?
|
Primates | 3 | 2022 | 545 | 0.360 |
Why?
|
Serotonin | 3 | 2022 | 1017 | 0.340 |
Why?
|
Substance-Related Disorders | 3 | 2020 | 4258 | 0.330 |
Why?
|
Sweetening Agents | 2 | 2010 | 296 | 0.320 |
Why?
|
GABA Modulators | 1 | 2008 | 107 | 0.310 |
Why?
|
GABA Agonists | 1 | 2008 | 111 | 0.310 |
Why?
|
Lorazepam | 1 | 2008 | 145 | 0.300 |
Why?
|
Drinking Behavior | 1 | 2007 | 103 | 0.290 |
Why?
|
Pyridazines | 1 | 2008 | 202 | 0.280 |
Why?
|
Ethanol | 2 | 2016 | 1342 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2008 | 575 | 0.270 |
Why?
|
Periodicity | 1 | 2007 | 363 | 0.270 |
Why?
|
Rats | 12 | 2019 | 24260 | 0.260 |
Why?
|
Rats, Long-Evans | 3 | 2012 | 387 | 0.260 |
Why?
|
Rats, Sprague-Dawley | 7 | 2019 | 8301 | 0.240 |
Why?
|
Benzodioxoles | 2 | 2021 | 69 | 0.240 |
Why?
|
Receptors, GABA-A | 1 | 2008 | 627 | 0.230 |
Why?
|
Anesthetics, Local | 1 | 2010 | 985 | 0.220 |
Why?
|
Amphetamine | 2 | 2017 | 225 | 0.210 |
Why?
|
Triazoles | 1 | 2008 | 911 | 0.210 |
Why?
|
Pyrrolidines | 2 | 2021 | 342 | 0.210 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2022 | 31 | 0.210 |
Why?
|
Drug Interactions | 3 | 2016 | 1460 | 0.200 |
Why?
|
Pyridines | 3 | 2016 | 2825 | 0.200 |
Why?
|
Hypnotics and Sedatives | 2 | 2018 | 1162 | 0.200 |
Why?
|
Pentanones | 1 | 2021 | 12 | 0.200 |
Why?
|
Drug-Seeking Behavior | 2 | 2019 | 48 | 0.200 |
Why?
|
Nicotinic Agonists | 2 | 2013 | 271 | 0.190 |
Why?
|
Feeding Behavior | 3 | 2016 | 3188 | 0.190 |
Why?
|
Male | 31 | 2024 | 350118 | 0.190 |
Why?
|
Neural Pathways | 2 | 2022 | 2972 | 0.180 |
Why?
|
Phosphocreatine | 1 | 2020 | 269 | 0.180 |
Why?
|
Fentanyl | 1 | 2022 | 410 | 0.170 |
Why?
|
Choline | 1 | 2020 | 493 | 0.170 |
Why?
|
Creatine | 1 | 2020 | 421 | 0.160 |
Why?
|
Stereoisomerism | 1 | 2019 | 624 | 0.160 |
Why?
|
Dextroamphetamine | 1 | 2018 | 129 | 0.160 |
Why?
|
Aspartic Acid | 1 | 2020 | 576 | 0.160 |
Why?
|
Disulfiram | 1 | 2018 | 57 | 0.160 |
Why?
|
Amphetamine-Related Disorders | 1 | 2018 | 67 | 0.160 |
Why?
|
Infusions, Subcutaneous | 1 | 2017 | 42 | 0.160 |
Why?
|
Acetylcysteine | 1 | 2019 | 272 | 0.150 |
Why?
|
Corpus Striatum | 1 | 2024 | 1221 | 0.150 |
Why?
|
Stress, Psychological | 1 | 2012 | 4245 | 0.140 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 175 | 0.140 |
Why?
|
Injections, Intramuscular | 1 | 2017 | 552 | 0.140 |
Why?
|
Psychotropic Drugs | 1 | 2021 | 894 | 0.130 |
Why?
|
Glutamic Acid | 1 | 2020 | 1169 | 0.130 |
Why?
|
Norepinephrine | 1 | 2017 | 909 | 0.130 |
Why?
|
Random Allocation | 1 | 2019 | 2429 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2020 | 1121 | 0.120 |
Why?
|
Cannabidiol | 1 | 2016 | 106 | 0.120 |
Why?
|
Methylphenidate | 1 | 2018 | 473 | 0.120 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1091 | 0.120 |
Why?
|
Psychomotor Performance | 2 | 2016 | 1901 | 0.120 |
Why?
|
Saimiri | 3 | 2021 | 330 | 0.120 |
Why?
|
Benztropine | 1 | 2013 | 17 | 0.120 |
Why?
|
Microdialysis | 1 | 2014 | 158 | 0.120 |
Why?
|
Antipsychotic Agents | 2 | 2022 | 3057 | 0.120 |
Why?
|
Autoantigens | 1 | 2017 | 892 | 0.110 |
Why?
|
Brain | 5 | 2022 | 26385 | 0.110 |
Why?
|
Arousal | 1 | 2018 | 1165 | 0.110 |
Why?
|
Psychology | 1 | 2014 | 356 | 0.100 |
Why?
|
Reaction Time | 1 | 2018 | 2097 | 0.100 |
Why?
|
Quinoxalines | 1 | 2013 | 290 | 0.100 |
Why?
|
Membrane Transport Proteins | 1 | 2017 | 1028 | 0.100 |
Why?
|
Receptors, sigma | 1 | 2011 | 28 | 0.100 |
Why?
|
Taste | 2 | 2010 | 176 | 0.100 |
Why?
|
Corticosterone | 1 | 2012 | 310 | 0.100 |
Why?
|
Oxalates | 1 | 2011 | 105 | 0.100 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2305 | 0.090 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 345 | 0.090 |
Why?
|
Carbazoles | 1 | 2011 | 226 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 35421 | 0.090 |
Why?
|
Aging | 1 | 2008 | 8664 | 0.090 |
Why?
|
Avoidance Learning | 2 | 2007 | 233 | 0.080 |
Why?
|
Motor Activity | 2 | 2017 | 2714 | 0.080 |
Why?
|
Cues | 2 | 2012 | 873 | 0.080 |
Why?
|
Genes, fos | 1 | 2008 | 183 | 0.080 |
Why?
|
Protein Binding | 1 | 2021 | 9386 | 0.080 |
Why?
|
Genes, Immediate-Early | 1 | 2008 | 101 | 0.080 |
Why?
|
Tobacco Use Disorder | 1 | 2013 | 688 | 0.080 |
Why?
|
Sex Characteristics | 2 | 2008 | 2585 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2010 | 6365 | 0.070 |
Why?
|
Protein Conformation | 1 | 2014 | 4011 | 0.070 |
Why?
|
Dopamine Agonists | 1 | 2008 | 355 | 0.070 |
Why?
|
Ataxia | 1 | 2008 | 304 | 0.070 |
Why?
|
Serotonin Antagonists | 1 | 2005 | 144 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6669 | 0.060 |
Why?
|
Cognition | 2 | 2019 | 6770 | 0.060 |
Why?
|
Female | 11 | 2024 | 380194 | 0.060 |
Why?
|
Piperidines | 1 | 2011 | 1602 | 0.060 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2022 | 63 | 0.050 |
Why?
|
Tetrahydronaphthalenes | 1 | 2022 | 89 | 0.050 |
Why?
|
Extinction, Psychological | 2 | 2019 | 376 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1312 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2016 | 3674 | 0.050 |
Why?
|
Time Factors | 3 | 2013 | 40075 | 0.050 |
Why?
|
Pyrazines | 1 | 2005 | 1230 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18029 | 0.040 |
Why?
|
Pentobarbital | 1 | 2018 | 155 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2019 | 216 | 0.040 |
Why?
|
Rats, Inbred F344 | 2 | 2009 | 862 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.040 |
Why?
|
Rats, Inbred Lew | 2 | 2009 | 1162 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2018 | 63114 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 647 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4933 | 0.030 |
Why?
|
Piperazines | 1 | 2005 | 2488 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11366 | 0.030 |
Why?
|
Species Specificity | 2 | 2009 | 2478 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 814 | 0.030 |
Why?
|
Photic Stimulation | 1 | 2019 | 2025 | 0.030 |
Why?
|
Anisoles | 1 | 2011 | 6 | 0.030 |
Why?
|
Radioligand Assay | 1 | 2011 | 374 | 0.020 |
Why?
|
Propylamines | 1 | 2011 | 165 | 0.020 |
Why?
|
Antazoline | 1 | 2009 | 6 | 0.020 |
Why?
|
Humans | 4 | 2024 | 744343 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1375 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9438 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2740 | 0.020 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2005 | 48 | 0.020 |
Why?
|
Mianserin | 1 | 2005 | 52 | 0.020 |
Why?
|
Mice | 3 | 2022 | 81183 | 0.020 |
Why?
|
Lithium Chloride | 1 | 2005 | 87 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1901 | 0.020 |
Why?
|
Neurons | 1 | 2024 | 9338 | 0.020 |
Why?
|
Motivation | 1 | 2013 | 1971 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2726 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2727 | 0.010 |
Why?
|
United States | 1 | 2014 | 69872 | 0.000 |
Why?
|
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_